Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$200M |
| 2 |
Danaher
DHR
|
+$146M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$138M |
| 4 |
Procter & Gamble
PG
|
+$122M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.89B |
| 2 |
Microsoft
MSFT
|
+$380M |
| 3 |
Alibaba
BABA
|
+$352M |
| 4 |
Wells Fargo
WFC
|
+$245M |
| 5 |
American Electric Power
AEP
|
+$243M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.41% |
| 2 | Technology | 7.27% |
| 3 | Financials | 6.46% |
| 4 | Consumer Discretionary | 5.3% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Howard Hughes
HHH
$3.81B
| $5.78M | 0.01% |
120,021
+52,048
| +77% | +$5.22M |
|
1202
Hershey
HSY
$35.2B
| $5.78M | 0.01% |
+43,619
| New | +$6.43M |
|
|
JIH
1203
DELISTED
Juniper Industrial Holdings, Inc.
JIH
| $5.77M | 0.01% |
+600,000
| New | +$5.89M |
|
1204
Edwards Lifesciences
EW
$49.6B
| $5.77M | 0.01% |
91,722
-1,260,546
| -93% | -$90.9M |
|
1205
Gibraltar Industries
ROCK
$1.25B
| $5.76M | 0.01% |
134,277
-315,495
| -70% | -$15.8M |
|
|
AMED
1206
DELISTED
Amedisys
AMED
| $5.76M | 0.01% |
31,382
-18,238
| -37% | -$3.24M |
|
1207
Equitable Holdings
EQH
$13B
| $5.76M | 0.01% |
398,389
-287,498
| -42% | -$6.28M |
|
1208
Tradeweb Markets
TW
$21.4B
| $5.75M | 0.01% |
136,682
-1,060,677
| -89% | -$48.6M |
|
1209
BancFirst
BANF
$3.79B
| $5.74M | 0.01% |
172,114
+73,795
| +75% | +$3.84M |
|
1210
Coherus Oncology
CHRS
$217M
| $5.73M | 0.01% |
353,446
-290,997
| -45% | -$5.38M |
|
1211
PUT
Biogen
BIIB
$30B
| $5.73M | 0.01% |
18,100
+13,500
| +293% | +$4.1M |
|
|
MNDT
1212
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $5.72M | 0.01% |
541,055
-1,203,860
| -69% | -$17.3M |
|
1213
TriNet
TNET
$3.02B
| $5.72M | 0.01% |
151,886
+55,484
| +58% | +$2.89M |
|
1214
State Street SPDR S&P Biotech ETF
XBI
$9.95B
| $5.72M | 0.01% |
73,844
-24,829
| -25% | -$2.2M |
|
1215
Eldorado Gold
EGO
$7.87B
| $5.71M | 0.01% |
924,789
-19,155
| -2% | -$144K |
|
1216
HealthEquity
HQY
$8.41B
| $5.7M | 0.01% |
112,716
-154,330
| -58% | -$10.2M |
|
|
GRMN
1217
Garmin
GRMN
$56.7B
| $5.69M | 0.01% |
75,948
-77,682
| -51% | -$7.03M |
|
1218
Comfort Systems
FIX
$60.9B
| $5.69M | 0.01% |
155,640
-202,906
| -57% | -$8.99M |
|
|
AGR
1219
DELISTED
Avangrid, Inc.
AGR
| $5.68M | 0.01% |
129,722
+117,996
| +1,006% | +$5.94M |
|
1220
CALL
iShares MSCI Mexico ETF
EWW
$1.92B
| $5.67M | 0.01% |
200,000
-350,000
| -64% | -$14.6M |
|
1221
10x Genomics
TXG
$6B
| $5.66M | 0.01% |
90,888
+65,802
| +262% | +$5.14M |
|
|
QTNT
1222
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $5.66M | 0.01% |
35,840
-4,005
| -10% | -$1.05M |
|
1223
Pacira BioSciences
PCRX
$1.04B
| $5.65M | 0.01% |
168,454
-118,226
| -41% | -$4.91M |
|
1224
CALL
Penumbra
PEN
$12.7B
| $5.65M | 0.01% |
35,000
+7,100
| +25% | +$1.2M |
|
1225
TriMas Corp
TRS
$1.43B
| $5.64M | 0.01% |
244,226
+153,637
| +170% | +$4.22M |
|
Similar funds
Millennium Management's Q1 2020 Portfolio in Review
As of Q1 2020, Millennium Management held 4,928 positions worth $44.5B, down 44% from $79.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management withdrew a net $21.4B in Q1 2020, closing 1,154 positions and reducing 1,745 holdings. Its most notable exit was Becton Dickinson, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Danaher worth $133M.
- Millennium Management's largest Q1 2020 buy was Danaher: 1,082,448 shares worth $133M.
- Millennium Management added most to Allergan plc in Q1 2020, an estimated $200M increase.
- Millennium Management's biggest Q1 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.89B.
- Millennium Management fully exited Becton Dickinson in Q1 2020, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 18% of its $44.5B portfolio in Q1 2020.
- Millennium Management opened 789 new positions and closed 1,154 in Q1 2020.
- Millennium Management's portfolio value fell 44% quarter-over-quarter to $44.5B.
Based on Millennium Management's 13F filing for Q1 2020, filed 14 May 2020.